Eloxx Pharmaceuticals, Inc. (ELOX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US29014R2022
Eloxx Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -6.44 m USD |
| EBIT | -6.00 m USD |
| Net income | -6.00 m USD |
| Diluted EPS – continuing operations | -0.49 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense mutations, cystic fibrosis with nonsense mutations, and nephropathic cystinosis with nonsense mutations, as well as in a preclinical stage for the treatment of autosomal dominant polycystic kidney disease with nonsense mutations. It has collaboration with Almirall, S.A. to develop and commercialize ZKN-013, an oral ribosome modulating agent for the treatment of rare skin diseases, such as recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa with nonsense mutations. Eloxx Pharmaceuticals, Inc. was incorporated in 1999 and is based in Arlington, Massachusetts.
More stocks
- Stablecoin Development Corp (SDEV)
- Yoong Onn Corporation Bhd (5159.KL)
- Empery Digital Inc. (EMPD)
- Taiwan Alpha Electronic Co Ltd (6204.TWO)
- Dongbang Agro (007590.KS)
- Hwacheon Mac (000850.KS)
- Wittchen SA (WTN.WA)
- MARTAS Precision Slide Co.,Ltd (6705.TWO)
- Techbond Group Bhd (5289.KL)
- Shan-Loong Transportation Co Ltd (2616.TW)
- CitroTech Inc. (CITR)
- Samik Pharm. (014950.KQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.